# Biostatistics Shared Resource

> **NIH NIH P30** · ROSWELL PARK CANCER INSTITUTE CORP · 2021 · $125,069

## Abstract

The Biostatistics Shared Resource (BIOSTATS) provides strategic support in the design, oversight,
implementation, analysis, publication, and reporting of scientific studies by Roswell Park researchers. In the
earliest stages of study development, we help to clarify aims and statistical outcomes, and to develop ethical,
rigorous, cost-effective designs. BIOSTATS focus is on conceptualizing and developing research projects,
analyses for publication, and the development of methodology clearly and closely related to the support of
specific projects within the Cancer Center. BIOSTATS provides support to Roswell Park CCSG investigators in
research ranging from laboratory, to clinical, to population studies In the reporting period (2013-2017),
BIOSTATS served a total of 195 Roswell users, of which 110 (57%) were CCSG members. BIOSTATS
provide a broad range of services including experimental design (including in vitro, animals, clinical trials,
epidemiology, and surveys), grant writing and collaboration, hypothesis formulation, exploratory data analysis,
fitting models to data, simulation studies, and development novel methods based on emerging technologies
(e.g., cutting-edge microarray platforms and computer-intensive statistical methods). The Specific Aims of
BIOSTATS are: 1) To enhance the productivity of Roswell Park investigators by providing rigorous,
comprehensive, and collaborative statistical support covering the spectrum of their research studies and grant
opportunities; 2) To maintain the integrity of the Roswell Park clinical trial portfolio by actively engaging in its
planning, oversight, review and management; and 3) To support the development of the next generation of
researchers through formal and ad-hoc training opportunities within Roswell Park, and through Research
Assistantships for Biostatistics students. Historically, BIOSTATS personnel focused primarily on clinical trials
design and analysis. Great strides have been made over the project period to expand our focus to
accommodate the growing needs in health behavior, cancer prevention and epidemiology, while keeping up
with the increase of clinical trials and basic research work. BIOSTATS plans to: (i) continue to provide timely
statistical support to basic, translational, clinical, and epidemiologic research. This support includes standard
methods and novel approaches developed within the shared resource; (ii) adopt adaptive designs for clinical
trials; (iii) expand educational activities focused on critical applied topics, such as study design, clinical trial
methods, and grant/protocol components; and (iv) enhance BIOSTATS billing, tracking, reporting and other
processes.

## Key facts

- **NIH application ID:** 10148649
- **Project number:** 5P30CA016056-44
- **Recipient organization:** ROSWELL PARK CANCER INSTITUTE CORP
- **Principal Investigator:** Austin Miller
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $125,069
- **Award type:** 5
- **Project period:** 1997-06-16 → 2024-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10148649

## Citation

> US National Institutes of Health, RePORTER application 10148649, Biostatistics Shared Resource (5P30CA016056-44). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10148649. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*